Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening

Por Coupé, V M H, Berkhof, J, Bulkmans, N W J, Snijders, P J F, Meijer, C J L M
Publicado em 2008

Multistate Statistical Modeling: A Tool to Build a Lung Cancer Microsimulation Model That Includes Parameter Uncertainty and Patient Heterogeneity

Por Bongers, Mathilda L., de Ruysscher, Dirk, Oberije, Cary, Lambin, Philippe, Uyl-de Groot, Carin A., Coupé, V. M. H.
Publicado no Med Decis Making (2015)

Scenario drafting for early technology assessment of next generation sequencing in clinical oncology

Por Joosten, S.E.P., Retèl, V.P., Coupé, V.M.H., van den Heuvel, M.M., van Harten, W.H.
Publicado no BMC Cancer (2016)

Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test

Por Rijkaart, D C, Coupe, V M H, van Kemenade, F J, Heideman, D A M, Hesselink, A T, Verweij, W, Rozendaal, L, Verheijen, R H, Snijders, P J, Berkhof, J, Meijer, C J L M
Publicado em 2010

High-Risk Human Papillomavirus (hrHPV) E6/E7 mRNA Testing by PreTect HPV-Proofer for Detection of Cervical High-Grade Intraepithelial Neoplasia and Cancer among hrHPV DNA-Positive...

Por Rijkaart, D. C., Heideman, D. A. M., Coupe, V. M. H., Brink, A. A. T. P., Verheijen, R. H. M., Skomedal, H., Karlsen, F., Morland, E., Snijders, P. J. F., Meijer, C. J. L. M.
Publicado em 2012

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications

Por Rijkaart, D C, Berkhof, J, van Kemenade, F J, Coupe, V M H, Rozendaal, L, Heideman, D A M, Verheijen, R H M, Bulk, S, Verweij, W, Snijders, P J F, Meijer, C J L M
Publicado em 2012

Prediction models for patients with esophageal or gastric cancer: A systematic review and meta-analysis

Por van den Boorn, H. G., Engelhardt, E. G., van Kleef, J., Sprangers, M. A. G., van Oijen, M. G. H., Abu-Hanna, A., Zwinderman, A. H., Coupé, V. M. H., van Laarhoven, H. W. M.
Publicado no PLoS One (2018)

Decision support systems for incurable non-small cell lung cancer: a systematic review

Por Révész, D., Engelhardt, E. G., Tamminga, J. J., Schramel, F. M. N. H., Onwuteaka-Philipsen, B. D., van de Garde, E. M. W., Steyerberg, E. W., Jansma, E. P., De Vet, H. C. W., Coupé, V. M. H.
Publicado no BMC Med Inform Decis Mak (2017)

Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyper...

Por Sluiter, N. R., de Cuba, E. M. V., Kwakman, R., Meijerink, W. J. H. J., Delis-van Diemen, P. M., Coupé, V. M. H., Beliën, J. A. M., Meijer, G. A., de Hingh, I. H. J. T., te Velde, E. A.
Publicado no Clin Exp Metastasis (2016)

Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis

Por Goos, J A C M, Coupe, V M H, Diosdado, B, Delis-Van Diemen, P M, Karga, C, Beliën, J A M, Carvalho, B, van den Tol, M P, Verheul, H M W, Geldof, A A, Meijer, G A, Hoekstra, O S, Fijneman, R J A
Publicado em 2013

Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases

Por Goos, J A C M, Hiemstra, A C, Coupé, V M H, Diosdado, B, Kooijman, W, Delis-Van Diemen, P M, Karga, C, Beliën, J A M, Menke-van der Houven van Oordt, C W, Geldof, A A, Meijer, G A, Hoekstra, O S, Fijneman, R J A
Publicado em 2014

Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer

Por de Cuba, E. M. V., de Hingh, I. H. J. T., Sluiter, N. R., Kwakman, R., Coupé, V. M. H., Beliën, J. A. M., Verwaal, V. J., Meijerink, W. J. H. J., Delis-van Diemen, P. M., Bonjer, H. J., Meijer, G. A., te Velde, E. A.
Publicado no Ann Surg Oncol (2016)